
Jeffrey E. Russel
Examiner (ID: 13185, Phone: (571)272-0969 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1815, 1103, 1621, 1811, 1653, 1675, 2899, 1654, 1809 |
| Total Applications | 3437 |
| Issued Applications | 2371 |
| Pending Applications | 237 |
| Abandoned Applications | 837 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7026438
[patent_doc_number] => 20050020494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Modified human growth hormone'
[patent_app_type] => utility
[patent_app_number] => 10/488662
[patent_app_country] => US
[patent_app_date] => 2002-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14756
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488662 | Modified human growth hormone | Aug 29, 2002 | Abandoned |
Array
(
[id] => 6711059
[patent_doc_number] => 20030170808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Transcription factor carp-2'
[patent_app_type] => new
[patent_app_number] => 10/204456
[patent_app_country] => US
[patent_app_date] => 2002-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9320
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204456
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204456 | Transcription factor carp-2 | Aug 20, 2002 | Abandoned |
Array
(
[id] => 243331
[patent_doc_number] => 07589065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds'
[patent_app_type] => utility
[patent_app_number] => 10/487750
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14186
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487750 | Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds | Aug 19, 2002 | Issued |
Array
(
[id] => 243331
[patent_doc_number] => 07589065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-15
[patent_title] => 'Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds'
[patent_app_type] => utility
[patent_app_number] => 10/487750
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14186
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/589/07589065.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487750
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487750 | Catalysis of the cis/trans-isomerisation of secondary amide peptide compounds | Aug 19, 2002 | Issued |
Array
(
[id] => 6740717
[patent_doc_number] => 20030158086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect'
[patent_app_type] => new
[patent_app_number] => 10/224283
[patent_app_country] => US
[patent_app_date] => 2002-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2656
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158086.pdf
[firstpage_image] =>[orig_patent_app_number] => 10224283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/224283 | Synthetic, statistic thymic peptide combination and its use as a preparation with immunological and/or endocrinological effect | Aug 19, 2002 | Abandoned |
Array
(
[id] => 1031251
[patent_doc_number] => 06878805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-12
[patent_title] => 'Peptide-conjugated oligomeric compounds'
[patent_app_type] => utility
[patent_app_number] => 10/222595
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 28619
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10222595
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/222595 | Peptide-conjugated oligomeric compounds | Aug 15, 2002 | Issued |
| 10/110060 | Compositions and methods for the incorporation of chemical substances into cells | Aug 11, 2002 | Abandoned |
Array
(
[id] => 7329819
[patent_doc_number] => 20040254119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Polypeptide conjugates with extended circulating half-lives'
[patent_app_type] => new
[patent_app_number] => 10/487025
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11025
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254119.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487025
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487025 | Polypeptide conjugates with extended circulating half-lives | Aug 8, 2002 | Issued |
Array
(
[id] => 7265306
[patent_doc_number] => 20040242842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use'
[patent_app_type] => new
[patent_app_number] => 10/486310
[patent_app_country] => US
[patent_app_date] => 2004-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4516
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242842.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486310
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486310 | Compositions of somatostatin analogues | Aug 6, 2002 | Issued |
Array
(
[id] => 1111323
[patent_doc_number] => 06806261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-10-19
[patent_title] => 'Methods for treating certain diseases using naaladase inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/209011
[patent_app_country] => US
[patent_app_date] => 2002-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9246
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/806/06806261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209011 | Methods for treating certain diseases using naaladase inhibitors | Jul 31, 2002 | Issued |
Array
(
[id] => 782986
[patent_doc_number] => 06992169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Carrier based drug delivery system'
[patent_app_type] => utility
[patent_app_number] => 10/210660
[patent_app_country] => US
[patent_app_date] => 2002-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 25540
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10210660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/210660 | Carrier based drug delivery system | Jul 30, 2002 | Issued |
Array
(
[id] => 1164057
[patent_doc_number] => 06759387
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-07-06
[patent_title] => 'Compositions and methods for enhancing drug delivery across and into epithelial tissues'
[patent_app_type] => B2
[patent_app_number] => 10/209421
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 41
[patent_no_of_words] => 27493
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/759/06759387.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209421 | Compositions and methods for enhancing drug delivery across and into epithelial tissues | Jul 29, 2002 | Issued |
Array
(
[id] => 946614
[patent_doc_number] => 06964948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Therapeutic peptide-based constructs derived from Domain II of bactericidal/permeability-increasing protein'
[patent_app_type] => utility
[patent_app_number] => 10/209621
[patent_app_country] => US
[patent_app_date] => 2002-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16566
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/964/06964948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10209621
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/209621 | Therapeutic peptide-based constructs derived from Domain II of bactericidal/permeability-increasing protein | Jul 29, 2002 | Issued |
Array
(
[id] => 554358
[patent_doc_number] => 07160856
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'α-O-linked glycoconjugates, methods of preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/205021
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 53
[patent_no_of_words] => 27408
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160856.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205021
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205021 | α-O-linked glycoconjugates, methods of preparation and uses thereof | Jul 24, 2002 | Issued |
Array
(
[id] => 6801631
[patent_doc_number] => 20030096796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Novel compounds and compositions as protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/205600
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41935
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096796.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205600
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205600 | Novel compounds and compositions as protease inhibitors | Jul 23, 2002 | Abandoned |
| 10/088078 | Anti cancer agent and method of treatment of cancer | Jul 21, 2002 | Abandoned |
Array
(
[id] => 1181495
[patent_doc_number] => 06737409
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-18
[patent_title] => 'Dolastatin 10 derivatives'
[patent_app_type] => B2
[patent_app_number] => 10/195698
[patent_app_country] => US
[patent_app_date] => 2002-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28393
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737409.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195698
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195698 | Dolastatin 10 derivatives | Jul 14, 2002 | Issued |
Array
(
[id] => 1005431
[patent_doc_number] => 06906027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-14
[patent_title] => 'Composition for nasal administration of insulin'
[patent_app_type] => utility
[patent_app_number] => 10/250862
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 7226
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/906/06906027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250862 | Composition for nasal administration of insulin | Jul 2, 2002 | Issued |
Array
(
[id] => 6706775
[patent_doc_number] => 20030153509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method of regulating glucose metabolism, and reagents related thereto'
[patent_app_type] => new
[patent_app_number] => 10/190267
[patent_app_country] => US
[patent_app_date] => 2002-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 19342
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153509.pdf
[firstpage_image] =>[orig_patent_app_number] => 10190267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/190267 | Method of regulating glucose metabolism, and reagents related thereto | Jul 2, 2002 | Issued |
Array
(
[id] => 1096284
[patent_doc_number] => 06821948
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'Conjugate for mediating cell, compartment or membrane-specific transport of active substances'
[patent_app_type] => B1
[patent_app_number] => 10/031505
[patent_app_country] => US
[patent_app_date] => 2002-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4147
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/821/06821948.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031505
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031505 | Conjugate for mediating cell, compartment or membrane-specific transport of active substances | Jul 1, 2002 | Issued |